COVID-19 World Map: 372,757 Confirmed Cases; 190 Countries; 16,231 Deaths

Note: There is now a newer Novel Coronavirus (COVID-19) Situation Report 65.

WHO Novel Coronavirus (COVID-19) Situation Report 64

• Four new countries/territories/areas from the South-East Asia Region (1), and Region of the Americas (3) have reported cases of COVID-19.
• WHO has delivered a new shipment of emergency medical supplies to the Islamic Republic of Iran as part of COVID-19 response measures. Details can be found on the WHO Regional Office for the Eastern Mediterranean here.
• The WHO WhatsApp Health Alert has now attracted 10 million users since launching Friday, and the COVID-19 Solidarity Response Fund has raised more than US$70 million, in just 10 days. The media briefing can be found here.
• WHOand FIFA launched a joint campaign to equip the football community to tackle COVID-19. This awareness campaign calls on all people around the world to follow the five key steps to stop the spread of the disease. More information can be found here.
• WHO and its partners are constantly working to strengthen the chains of essential COVID-19 supplies. As global demand rises, WHO and its partners aim to ensure assistance to areas most in need. More information can be found in Subject in Focus.

Risk Assessment

Global Level: Very High

Coronavirus Situation in Numbers

Globally

• 372,757 confirmed cases (39,827 new)
• 16,231 deaths (1,722 new)

Western Pacific Region

• 96,580 confirmed cases (943 new)
• 3,502 deaths (29 new)

European Region

• 195,511 confirmed cases (24,087 new)
• 10,189 deaths (1,447 new)

South-East Asia

• 1,990 confirmed cases (214 new)
• 65 deaths (7 new)

Eastern Mediterranean Region

• 27,215 confirmed cases (1,840 new)
• 1,877 deaths (136 new)

Regions of the Americas

• 49,444 confirmed cases (12,428 new)
• 565 deaths (100 new)

African Region

• 1305 confirmed cases (315 new)
• 26 deaths (3 new)

Subject In Focus: Strengthening Supply Chains to Create Greatest Impact

WHO and the World Food Programme (WFP) are exploring ways to work with the Pandemic Supply Chain Network (PSCN) and Logistical Emergency Teams (L.E.T.) to ensure that logistical assets are in place to support the increasing global demand for COVID-19 supplies. This is to ensure that supplies are allocated effectively and equitably in the places where they are needed the most.

WHO is also working with the World Bank to develop demand modeling from a country-based perspective. This will allow the sharing and support of technical guidance and allocation mechanisms and ensure that critical supplies are distributed with most impact.

The planning effort will support the mapping of scenarios as well as what is needed for stocks and procurement. With the engagement of the World Bank, the PSCN seeks to bring together the overview of the market’s capability to provide and distribute the necessary supplies, WHO demand forecasting and the necessary financial and political support to fight COVID-19.

Representatives from both WFP and the United Nations Office for the Coordination of Humanitarian Affairs (OCHA)have joined the WHO team at HQ to establish the Supply Chain Coordination Cell (SCCC). The objectives of the SCCC are to:

• Establish a COVID-19 supply chain working group to deepen inter-agency collaboration with the aim of minimizing disruptions to current humanitarian operations, while increasing the efficiency and coherence of the COVID-19 response.
• Provide a centralized voice through the collection and dissemination of information to the UN Crisis Management Team (UNCMT), other relevant forums, as well as the wider humanitarian community, to support strategic guidance, operational decision-making, and overall monitoring.
• Foster the creation of regional and country level coordination mechanisms aimed at implementing efforts, while maintaining the overall coordination of the response.
• Create a smaller joint procurement group of medical equipment buying agencies.

WHO and its partners are constantly working to strengthen the chains of essential COVID-19 supplies. As global demand rises, WHO and its partners aim to ensure that those areas most at need receive as much assistance as much as possible.

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, March 24, 2020

Country/Territory/Area	Confirmed Cases
China	81747
Italy	63927
United States of America	42164
Spain	33089
Germany	29212
Iran	23049
France	19615
Republic of Korea	9037
Switzerland	8015
United Kingdom	6654
Netherlands	4749
Austria	4486
Belgium	3743
Norway	2371
Portugal	2060
Sweden	2016
Australia	1709
Brazil	1546
Turkey	1529
Malaysia	1518
Denmark	1460
Canada	1432
Israel	1238
Czech Republic	1236
Japan	1128
Ireland	1125
Pakistan	887
Luxembourg	875
Thailand	827
Ecuador	790
Poland	749
Chile	746
International (Diamond Princess Cruise Ship)	712
Finland	700
Greece	695
Iceland	588
Indonesia	579
Romania	576
Saudi Arabia	562
Singapore	507
Qatar	501
Philippines	462
Slovenia	442
Russian Federation	438
India	434
South Africa	402
Peru	395
Bahrain	377
Mexico	370
Egypt	366
Estonia	352
Panama	345
Croatia	306
Colombia	277
Lebanon	267
Argentina	266
Iraq	266
Serbia	249
Dominican Republic	245
Armenia	235
Algeria	231
Bulgaria	201
United Arab Emirates	198
Kuwait	191
Slovakia	191
Hungary	187
San Marino	187
Latvia	180
Lithuania	179
Andorra	164
Uruguay	162
Costa Rica	158
Morocco	143
North Macedonia	136
Bosnia and Herzegovina	131
Jordan	127
Albania	123
Vietnam	123
Faroe Islands	118
Cyprus	116
Republic of Moldova	109
Malta	107
New Zealand	102
Burkina Faso	99
Sri Lanka	97
Brunei Darussalam	91
Tunisia	89
Cambodia	87
Oman	84
Ukraine	84
Belarus	81
Senegal	79
Azerbaijan	72
Cameroon	72
Réunion	71
Venezuela	70
Georgia	67
Kazakhstan	63
Guadeloupe	62
Kosovo	61
Palestinian Territory	59
Martinique	53
Trinidad and Tobago	51
Liechtenstein	46
Uzbekistan	46
Afghanistan	42
Cuba	40
Democratic Republic of the Congo	36
Mauritius	36
Rwanda	36
Bangladesh	33
Puerto Rico	31
Honduras	30
Guam	29
Côte d’Ivoire	25
Bolivia	27
Ghana	27
Mayotte	24
Monaco	23
Montenegro	22
Nigeria	22
Paraguay	22
Jamaica	19
French Guiana	20
Guatemala	20
Guernsey	20
French Polynesia	18
Jersey	18
Togo	18
Barbados	17
Virgin Islands	17
Kenya	16
Kyrgyzstan	16
Gibraltar	15
Isle of Man	13
Madagascar	13
Maldives	13
United Republic of Tanzania	12
Ethiopia	11
Mongolia	10
Aruba	9
Uganda	9
New Caledonia	8
Saint Martin	8
Seychelles	7
Bermuda	6
Equatorial Guinea	6
Gabon	6
Haiti	6
Benin	5
Cayman Islands	5
Guyana	5
Bahamas	4
Central African Republic	4
Congo	4
Curaçao	4
Eswatini	4
Greenland	4
Cabo Verde	3
Djibouti	3
El Salvador	3
Fiji	3
Liberia	3
Namibia	3
Saint Barthelemy	3
Zambia	3
Angola	2
Bhutan	2
Chad	2
Guinea	2
Mauritania	2
Myanmar	2
Nepal	2
Nicaragua	2
Niger	2
Saint Lucia	2
Sint Maarten	2
Sudan	2
Suriname	2
Zimbabwe	2
Antigua and Barbuda	1
Belize	1
Dominica	1
Eritrea	1
Gambia	1
Grenada	1
Holy See	1
Montserrat	1
Mozambique	1
Papua New Guinea	1
Saint Vincent and the Grenadines	1
Somalia	1
Syrian Arab Republic	1
Timor-Leste	1
Turks and Caicos	1
Total	372757

Recommendations and Advice for the Public

If you are not in an area where COVID-19 is spreading or have not traveled from an area where COVID-19 is spreading or have not been in contact with an infected patient, your risk of infection is low. It is understandable that you may feel anxious about the outbreak. Get the facts from reliable sources to help you accurately determine your risks so that you can take reasonable precautions (see Frequently Asked Questions). Seek guidance from WHO, your healthcare provider, your national public health authority or your employer for accurate information on COVID-19 and whether COVID-19 is circulating where you live. It is important to be informed of the situation and take appropriate measures to protect yourself and your family (see Protection measures for everyone).

If you are in an area where there are cases of COVID-19 you need to take the risk of infection seriously. Follow the advice of WHO and guidance issued by national and local health authorities. For most people, COVID-19 infection will cause mild illness however, it can make some people very ill and, in some people, it can be fatal. Older people, and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are at risk for severe disease (See Protection measures for persons who are in or have recently visited (past 14 days) areas where COVID-19 is spreading).

Case Definitions

WHO periodically updates the Global Surveillance for human infection with coronavirus disease (COVID-19) document which includes case definitions.

For easy reference, case definitions are included below.

Suspect case

A. A patient with acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g., cough, shortness of breath), AND a history of travel to or residence in a location reporting community transmission of COVID-19 disease during the 14 days prior to symptom onset.

 OR

B. A patient with any acute respiratory illness AND having been in contact with a confirmed or probable COVID-19 case (see definition of contact) in the last 14 days prior to symptom onset;

 OR

C. A patient with severe acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g., cough, shortness of breath; AND requiring hospitalization) AND in the absence of an alternative diagnosis that fully explains the clinical presentation.

Probable case

A. A suspect case for whom testing for the COVID-19 virus is inconclusive.

a. Inconclusive being the result of the test reported by the laboratory.

 OR

B. A suspect case for whom testing could not be performed for any reason.

Confirmed case

A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.

• Technical guidance for laboratory testing can be found here.

Definition of contact

A contact is a person who experienced any one of the following exposures during the 2 days before and the 14 days after the onset of symptoms of a probable or confirmed case:

1. Face-to-face contact with a probable or confirmed case within 1 meter and for more than 15 minutes;
2. Direct physical contact with a probable or confirmed case;
3. Direct care for a patient with probable or confirmed COVID-19 disease without using proper personal protective equipment; OR
4. Other situations as indicated by local risk assessments.

Note: for confirmed asymptomatic cases, the period of contact is measured as the 2 days before through the 14 days after the date on which the sample was taken which led to confirmation.